101 related articles for article (PubMed ID: 18835343)
1. Particulate drug interactions with polymeric and elastomeric valve components in suspension formulations for metered dose inhalers.
James J; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2009 Jan; 366(1-2):124-32. PubMed ID: 18835343
[TBL] [Abstract][Full Text] [Related]
2. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
3. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
[TBL] [Abstract][Full Text] [Related]
4. Surface energy and interparticle forces correlations in model pMDI formulations.
Traini D; Rogueda P; Young P; Price R
Pharm Res; 2005 May; 22(5):816-25. PubMed ID: 15906178
[TBL] [Abstract][Full Text] [Related]
5. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
D'Sa D; Chan HK; Chrzanowski W
Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
[TBL] [Abstract][Full Text] [Related]
6. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
Bouhroum A; Burley JC; Champness NR; Toon RC; Jinks PA; Williams PM; Roberts CJ
Int J Pharm; 2010 May; 391(1-2):98-106. PubMed ID: 20184946
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy.
Ashayer R; Luckham PF; Manimaaran S; Rogueda P
Eur J Pharm Sci; 2004 Mar; 21(4):533-43. PubMed ID: 14998585
[TBL] [Abstract][Full Text] [Related]
8. Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Int J Pharm; 2006 Aug; 320(1-2):58-63. PubMed ID: 16735100
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
10. A model for predicting size distributions delivered from pMDIs with suspended drug.
Stein SW; Sheth P; Myrdal PB
Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
[TBL] [Abstract][Full Text] [Related]
11. Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope.
Young PM; Price R; Lewis D; Edge S; Traini D
J Colloid Interface Sci; 2003 Jun; 262(1):298-302. PubMed ID: 16256608
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.
Alatrash A; Matida E
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):501-513. PubMed ID: 27504720
[TBL] [Abstract][Full Text] [Related]
13. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
[TBL] [Abstract][Full Text] [Related]
14. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
15. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
Rogueda PG; Price R; Smith T; Young PM; Traini D
J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
[TBL] [Abstract][Full Text] [Related]
16. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
Dhand R
Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of the OptiChamber Diamond valved holding chamber.
Hatley RH; von Hollen D; Sandell D; Slator L
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
[TBL] [Abstract][Full Text] [Related]
18. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs.
Stein SW; Sheth P; Younis US; Mogalian E; Myrdal PB
Mol Pharm; 2015 Sep; 12(9):3455-67. PubMed ID: 26258647
[TBL] [Abstract][Full Text] [Related]
19. Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers.
Vehring R; Lechuga-Ballesteros D; Joshi V; Noga B; Dwivedi SK
Langmuir; 2012 Oct; 28(42):15015-23. PubMed ID: 22985189
[TBL] [Abstract][Full Text] [Related]
20. Pressurized Metered-Dose Inhalers Versus Nebulizers in the Treatment of Mechanically Ventilated Subjects With Artificial Airways: An In Vitro Study.
Ari A; Harwood RJ; Sheard MM; Fink JB
Respir Care; 2015 Nov; 60(11):1570-4. PubMed ID: 26152470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
